Arthroscopy Devices – Increasing Geriatric Population Provides a Sea of Opportunities

Arthroscopy is a minimally invasive surgical procedure performed by surgeons to visualize, diagnose and treat the joint related disease. The surgeon makes a small incision through which they insert the probe contain a small lens and lightening system to visualize the inside structure. The arthroscopic surgery is performed to treat the acute or chronic injury related to knee, shoulder, hip and wrist by avoiding post-surgery complications, infection and appears minimum scars at surgery site.

Get More Information: http://bit.ly/2sSLlLK

There are various applications of arthroscopy devices in knee, shoulder and hip implantation and among these knee implantation contributes the major market share followed by shoulder implantation supported by the increase in cases of knee and shoulder replacement surgery procedures worldwide due to increase in number of obese and aging population.

Among product types, the arthroscopy implants segment accounts for major market share and is expected to retain its dominance throughout the forecast period. This is mainly attributed to increasing number of knee, shoulder and hip implantation surgeries worldwide.

Market Dynamics

Rapid advancements in technology has led to increasing adoption of arthroscopy devices, in turn creating a highly conducive environment for growth of the market. It is expected that North America and Asia-Pacific region will show high growth rate during the forecast period, mainly due to increasing geriatric population and growing number of injuries necessitating knee and shoulder surgery.

The surgery is especially preferred by sportspersons, due to its low recovery time and minimally-invasive nature. Also, the growth is supported by increased rate of knee surgery. The leading cause behind increased rate of joint pain is overweight and aging population.

Request Sample: http://bit.ly/2UsJysX

Market Taxonomy

This report segments the global arthroscopy devices market on the basis of product type, application, and geography. On the basis of product type, the market is categorized into arthroscopes, arthroscopy shavers, arthrosopy fluid management system, arthroscopy implants, arthroscopy radio frequency systems and arthroscopy visualization systems. On the basis of therapeutic application, the market is divided into knee implants, shoulder implants, hip implants and others. Among all therapeutic application, knee implants segment dominated the arthroscopy devices market, due to increase in knee implant surgery procedure rate around the globe.

Key features of the study:

• This report provides in-depth analysis of the arthroscopy devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global arthroscopy devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
• Key companies covered as a part of this study include Smith & Nephew, Olympus Inc., Karl Storz, Stryker Corporation, CONMED Corporation, Vimex Sp. z o.o. and DePuy Synthes Inc.
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, end user upgrades, market expansion, and marketing tactics
• The global arthroscopy devices market report caters to various stakeholders in this industry, including investors, device manufacturers, distributors and suppliers for arthroscopy devices, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the arthroscopy devices market would provide stakeholders vital inputs to make strategic decisions accordingly

Anti-Suicide Drugs Market – Beacon Light of Life on the Horizon

Anti-Suicide Drugs – Beacon Light of Life on the Horizon

Depression is one of the major healthcare burdens worldwide leading to lower productivity and in severe cases leading to suicidal tendencies. Anti-depressant and anti-psychotic drugs are especially high in demand during economic crisis and social negligence. These drugs also serve as a therapy for preventing suicidal thoughts and attempts. However, overdose of these drugs can be fatal and therefore, needs to be administered under the direction of a physician. Extensive research related to suicide treatment is expected to provide a better solution to the global population during the latter half of the forecast period (2016-2024). This would improve the outlook of global anti-suicide drugs market and would help in reducing deaths due to suicide.

The global anti-suicide drugs market was valued at US$ 3,318.3 million in 2015 and is expected to witness a moderate CAGR of 4.2% during the forecast period (2016 – 2024).

Request Sample: http://bit.ly/2Tf80xu

Figure 1. Global Anti-Suicide Drugs Market, Drug Pipeline Snapshot

  

Source: Coherent Market Insights Analysis (2017)

Companion Diagnostics Market Expected to Remain High in North America during 2018-2026

Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying genetic mutations and the health and treatment approach implications. In July 2016, the U.S. FDA released a draft guideline for development of a therapeutic product accompanying an IVD companion diagnostic. Companion diagnostics include Gleevec (imatinib mesylate) and BCR-ABL LDT and DAKO C-KIT PharmDx, Herceptin (trastuzumab) and DAKO Herceptest; and Nolvaldex (tamoxifen) and laboratory-developed estrogen receptor positive test.

Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/109

Market Dynamics

Companion diagnostics are beneficial for pharmaceutical companies who face challenges with respect to high drug development cost, safety and outcome of clinical trials, and long product approval time. Companion diagnostics lowers development costs, improves time to market and enhances drug safety by enabling rapid identification of target biomarker and the most effective drug therapy. For patients, the technology provides better treatment outcomes and lower morbidity risk. Use of technologies such as PCR, immunohistochemistry, and gene sequencing has enabled accurate diagnosis and determination of targeted cancer therapy. As the CDx tests also aid in revealing the off-target effects of a drug along with identification of a molecular target, CDx have become and indispensable tool for oncologists.

Research collaborations to improve the time to market the product

An integrated and more evidence-based approach is driving partnerships in the global companion diagnostics market. According to Wildwood Ventures Ltd., the number of global deal in companion diagnostics market has increased from 13 in 2007 to 66 in 2013. Since, developing CDx test along with drug therapy is a capital intensive and complex process, industry players are collaborating to leverage on each other’s expertise. For instance:

• Invivoscribe Technologies Inc., collaborated with Novartis AG and Astellas Pharma Inc. to develop companion diagnostics for their drugs under pipeline.

• Invivoscribe also announced a long-term partnership with Thermo Fisher Scientific in January 2017, develop and commercialize IVD assays for Applied Biosystems® 3500 Dx Series Genetic Analyzers. Invivoscribe Technologies Inc. is a global company engaged in providing clonality and biomarker test solutions for oncology and personalized molecular diagnostics.

• AstraZeneca plc entered into a deal with Abbott Laboratories, Inc. in 2015, to develop a companion diagnostic test for tralokinumab, used for treating severe asthma.

• Singulex, Inc. entered into a strategic collaboration with QIAGEN N.V. in January 2017 to develop companion diagnostics using Singulex's proprietary Single Molecule Counting (SMC) immunodiagnostic platform

Increasing number of research collaborations is expected to improve the time to market of highly effective targeted drug therapies. This would in-turn augment the growth of companion diagnostics market.

Market Taxonomy

This report segments the global companion diagnostics market on the basis of application, technology, and geography. On the basis of application, the market is categorized into breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma, and others. On the basis of technology, the market is segmented into immunohistochemistry, real-time PCR, gene sequencing, Fluorescence in situ hybridization (FISH), and others. For comprehensive understanding of market dynamics, the global companion diagnostics market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Detailed Segmentation:

Global Companion Diagnostics Market, By Application:

• Breast Cancer

• Lung Cancer

• Colorectal Cancer

• Gastric Cancer

• Melanoma

• Others

Global Companion Diagnostics Market, By Technology:

• Immunohistochemistry

• Real-time PCR

• Gene Sequencing

• FISH

• Others

Global Companion Diagnostics Market, By Geography:

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East

• Africa

Else place an Enquiry Before Purchase " Companion Diagnostics Market Size, Share, Outlook, Forecast" Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/109

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Dental Equipment Market to Showcase Healthy Expansion of CAGR By 2024

Practice of dentists has shifted from being focused on disease treatment to preventive measures. This change in market dynamics is acting as a catalyst for development of new technologies for diagnosis and treatment of dental issues Growing awareness about dental care among consumers has translated into rising number of routine-check-ups and growing spending on maintaining oral health. This is in turn spurring demand for dental care equipment, including dental lasers, imaging systems, and computer-aided design and computer-aided manufacturing (CAD/CAM) systems.

Market Dynamics

Dental equipment finds extensive application in diagnosis and treatment of dental disorders such as dental cavities, gingival disease, and periodontal (gum) disease. Advent of 3D printing in dental industry creates a highly favorable environment conducive for market growth and helps dentists provide better services through use of highly efficient diagnostic and treatment tools. Moreover, growing public awareness about dental treatment options, coupled with increasing expenditure on dental care is driving patients to opt for preventive measures. According to a study published in the American Dental Association’s research paper of 2014, around 52.3% of adults in the U.S. visited a dentist every six months. Focus on enhancing patient’s experience through high-quality treatment outcomes is driving demand for dental equipment worldwide.

Request For Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/85

Development of CAD/CAM & 3D printing is expected to drive dental equipment market growth

Incision during surgeries can be carried out precisely by using laser and electro surgery techniques. This will reduce the damage caused to tissues and will aid in faster healing. The time taken for prosthodontic restoration procedures has reduced to one day due to the development of CAD/CAM. By replacing conventional radiology equipment with digital radiology equipment equipped with picture archiving and communication systems (PACS), treatment records can be archived. Moreover, outcomes of dental treatments have improved due to 3D printing technology. When compared to the conventional CT systems, cone beam CT systems provides clear extra oral images and exposure to harmful X-rays will be minimal.

Increasing preference for refurbished dental equipment impacting the growth of overall dental equipment market

Budget constraints in emerging countries such as India, China, Brazil and Eastern European countries is driving demand for refurbished dental equipment. This aids the newly established dental clinics and laboratories to achieve cost-efficiency with quality throughput. New dental equipment such as cone beam CT systems, vacuums & compressors, cad/cam, digital X-ray units and laboratory equipment involve high capital investment. This may increase the cost of patient dental procedures, thus negatively impacting the number of patient visits. Therefore, most dentists and hospitals in emerging countries prefer refurbished equipment, which in turn helps them pass on the cost-saving benefits to their patients. Market players such as Danaher Corporation, Planmeca Oy, and Dentsply Sirona, Inc. must consider the cost parameters while targeting the cost-sensitive customer base in emerging countries that are projected to be highly lucrative dental equipment markets in the near future.

Market Taxonomy

This report segments the global dental equipment market on the basis of equipment type and end user. On the basis of equipment type, the market is classified as dental imaging equipment, dental lasers, dental laboratory equipment, hygiene maintenance devices, systems and parts, and others. End users of these equipment are hospitals, dental clinics, and dental laboratories.

Global Key Players

A-Dec Inc., 3M ESPE, Carestream Heath, Inc., Biolase Inc., Noble Biocare, Danaher Corporation, Ivoclar Vivadent AG, Dentsply Sirona, Inc., Henry Schein, Inc., Patterson Companies Inc., Planmeca Oy, and Institut Straumann AG.

Detailed Segmentation:

Global Dental Equipment Market, By Equipment Type:

• Dental imaging equipment

• Dental lasers

• Dental laboratory equipment

• Hygiene maintenance devices

• Systems and parts

• Other dental equipment

Global Dental Equipment Market, By End User:

• Hospitals

• Dental clinics

• Dental laboratories

Global Dental Equipment Market, By Geography:

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East

• Africa

Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/85

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Gel Permeation Chromatography Market Industry Insights, Outlook By 2018-2026

The gel permeation chromatography market is expected to gain significant traction with increasing development in novel drugs and excipients by manufacturers and increasing R&D initiatives by research foundations. Furthermore, new product launches and regulatory demand for manufacturing quality pharmaceuticals is expected to drive growth of the market for the gel permeation chromatography market.

Key players operating in gel permeation chromatography market are Agilent Technologies, Waters Corporation, Malvern Panalytical, Shimadzu Corporation, and Polymer Char.

Get Access to TOC / Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/28

Key players are launching innovative products in gel permeation chromatography system and component, in order to cater to increasing demand. For instance, in January 2015, Malvern Instruments launched novel OMNISEC gel permeation chromatography/ size exclusion chromatography system, which has one of most sensitive light scattering detector that allows measurement even at minute sample quantity. It has multidetectors component OMNI REVEAL that has different kinds of detectors such as refractive index meter, light scattering detectors, and Viscometer, which allows precise measurement of different analytes.

Postnova Analytics in 2016, launched first filed flow fractionation based gel permeation chromatography instrument called TF2000 Thermal FFF, which allows better separation and purification of polymers over conventional GPC system. In 2016, Agilent launched AdvanceBio size exclusion chromatography columns at Analytica China.

Companies are focusing on co-marketing agreement, for integration of component of one company with GPC systems of other. For instance, in January 2018, Waters Corporation and Malvern Panalytical entered into a co-marketing agreement with Malvern Panalytical. It would result in pairing of the Waters ACQUITY Advanced Polymer Chromatography System with Malvern Panalytical’ s OMNISEC REVEAL, which provides high sensitivity, higher resolution data, and access to samples without the need for column calibration.

Some companies are focusing on mergers to expand their footprint in the global market. For instance, in 2017, Malvern Instruments Ltd. and PANalytical B.V. merged together, and combined to form an entity, Malvern Panalytical. In 2014, Malvern acquired MicroCal from GE healthcare whose microcalorimetry range is used for its innovative OMNISEC GPC/SEC platform

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/28

Detailed Segmentation:

Global Gel Permeation Chromatography Market, By Product Type:

Gel Permeation Chromatography System

Detectors

Columns

Pumps

Global Gel Permeation Chromatography Market, By End User:

Pharmaceutical and Biotech Companies

Research Institutes

Global Gel Permeation Chromatography Market, By Region:

North America

By Product Type:

Gel Permeation chromatography system

Detectors

Columns

Pumps

By End User:

Pharmaceutical and Biotech Companies

Research Institutes

By Country:

U.S.

Canada

Get Discount @ https://www.coherentmarketinsights.com/insight/request-discount/28

Cardiovascular Information System Market - Global Forecast to 2026

Global Cardiovascular Information System Market, By Region

The Global Cardiovascular Information System Market, by Component (Software, and Services), by Deployment (Cloud-Based and On-Premise), by Application (Cardiac and Peripheral Catheterization, Hemodynamics Monitoring, Electrophysiology, Echocardiography, and Others), By End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Clinics) was valued at US$ 668.3 million in 2017 and is projected to exhibit a CAGR of 8.5% over the forecast period (2018 - 2026) as highlighted in a new report published by Coherent Market Insights.

Request Sample

The cardiovascular information systems provide a single interface and exclude the requirement of various subsystem connections, which in turn helps to simplify enterprise-wide access to cardiology department data by eliminating the need to re-enter patient data, and save time by eliminating the need to search for patient data in various IT systems or physical locations. Many healthcare providers are trying to modernize their cardiovascular departments with cardiovascular information system (CVIS), which will help in optimizing the cardiovascular service line. One of the products of GE Healthcare - Centricity Cardiology Enterprise is an integrated imaging and workflow solution that provides a unified view of cardiology and radiology images with customizable workflows. In 2015, this product received North American Cardiology Informatics Market Leadership Award Recipient. Thus, growing popularity of these devices among various healthcare providers is expected to drive growth of cardiovascular information system market over the forecast period.

Browse 25 Market Data Tables and 44 Figures spread through 173 Pages and in-depth TOC on "Cardiovascular Information System Market, by Component (Software, and Services), by Deployment (Cloud-Based and On-Premise), by Application (Cardiac and Peripheral Catheterization, Hemodynamics Monitoring, Electrophysiology, Echocardiography, and Others), By End User (Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, and Clinics) - Global Forecast to 2026"

Vendors are engaged in developing advanced software with more powerful database to improve clinical and financial performance of cardiology department. For instance, on March, 2015, Philips launched IntelliSpace Cardiovascular at the American College of Cardiology Conference. This system is a web-enabled image and information management system with a single integrated workspace that produces a holistic view of the patient’s care and allows cardiologists to collaborate and share information more readily with other team members across various care settings to make timely and informed decisions to improve patient management.

Get Discount 

Key takeaways of the cardiovascular information system market:

• The global cardiovascular information system market is expected to expand at a CAGR of 8.5% during the forecast period (2018–2026), owing to technological advancements and large product base of life science microscopes
• On the basis of components, service segment is expected to show maximum traction during the forecast period, owing to the rising need to integrate CVIS with many other technologies such as CPACS/EMR and other cardiology modules, which require proper knowledge and IT specialist to understand the working and other needs of the technology
• Cloud-based deployment hold major market share, owing to improved interoperability, reduction in IT burden in hospitals, and easy remote access to data and images
• On the basis of end user, hospitals hold largest market share, as hospitals have high purchasing power due to which adoption rate for CVIS solutions becomes high
• Some of the major players operating in the global cardiovascular information system market include Olympus Corporation, Thermo fisher Scientific, Inc., Nikon Corporation, Carl Zeiss AG, Keyence Corporation, JEOL Ltd., Bruker, Hitachi High-Technologies Corporation, Leica Microsystems, and F. Hoffman-La Roche Ltd.

Talk To Analyst

At 32.5%+ CAGR, Car T Cell Therapy Market will Reach US$ 7.7 Billion by 2028

Key players in the market are engaged in extensive research and development to launch new targeted cell therapies in the market. For instance, the University of Texas MD Anderson Cancer Center, Houston is conducting phase 1 clinical trial studies of central memory–derived CD19 CAR T–cell therapy for relapsed intermediate-grade B-cell non-Hodgkin lymphoma. Moreover, key players are focusing on strategic merger and acquisition to enhance their share in the global CAR-T cell therapy market. For instance, in April 2018, Pfizer, Inc. signed a deal with Allogene, to develop an investigational CAR-T cell therapy for treating cancer.

Request Sample

Key players operating in the global CAR-T cell therapy market include Novartis International AG, Kite Pharma, Inc. (Gilead Sciences, Inc.), Juno Therapeutics (Celgene Corporation), Bluebird Bio, Inc. (Celgene Corporation), Sorrento Therapeutics Inc., Mustang Bio, Inc., Aurora Biopharma Inc., Legend Biotech (Genscript Biotech Corporation), Pfizer, Inc., CARsgen Therapeutics, Ltd., and others.

CAR-T cell therapy is expected to be an important development in cancer treatment and therapeutics industry due to its cost efficiency. Moreover, rising incidence of cancer is leading to high demand for its treatment.

According to the World Cancer Research Fund International (WCRFI), around 14.1 million cancer cases were reported worldwide, in 2012. As per WCRFI, it is projected that by 2035, around 24 million cancer cases would be observed worldwide.

Moreover, introduction of new therapies into the market is further expected to bolster growth of CAR-T cell therapy market. For instance, in October 2017, the U.S. Food and Drug Administration granted marketing approval to Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma.

CAR T cell therapy market is expected to be primarily driven by increasing demand for highly effective therapy mode of treating cancer. Combating cancer has been a major concern for healthcare industry for years.

CAR T cell works on gene transfer technology that boosts the immune response of cancer affected individual by destroying affected tumor cells. It has been analyzed to act as a lifesaving drug for over 30 million patients’ sufferings from lymphoma. Though the CAR T cell therapy market outlook is highly optimistic, market players need to address the manufacturing and scalability options to generate higher profits. Novartis and Kite have already started building a roadmap for it.

Talk To Analyst

Anti-Suicide Drugs Market - Outstanding Share Contributed by Healthcare and Medical Sector to Expand the Market

Global Anti-Suicide Drugs Market

Suicidal thoughts can be aroused due to various underlying factors such as financial burden, social issues or drug side effects. Treatment for suicidal thoughts includes psychotherapy, medications, addiction treatment, and family support. Anti-depressants and anti-psychotics are the most widely used medications for treating suicidal tendencies. According to the World Health Organization (WHO), over 800,000 people die due to suicide annually. Development of an effective anti-suicidal drug could be a major breakthrough in reducing the death toll. Currently, non-profit organizations such as Stop Suicide, Stop Youth Suicide, and American Foundation for Suicide Prevention are providing moral and social support to people with reported suicidal thoughts. This however, is ineffective until the organization is alerted of the person at risk for suicide.

Request For Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/10

Market Dynamics

Off-label use of these drugs for suicidal ideation has been a practice for years, as there are no approved anti-suicide specific drug yet. However, the dynamics is expected to change in the following few years with the launch of first oral therapeutic drug for acute suicidal ideation. This would disrupt the use of antidepressants and anti-psychotic drugs for the treatment of suicidal tendencies. Suicidal incidences are high in low and middle income countries according to the WHO 2016 statistics. Although the incidence in Asia, East Africa, and Eastern European region is high, these regions lag in terms of availability of affordable medications and healthcare facilities. Therefore developed economies of North America and Western Europe are key target regions for manufacturers in the near future. Rampant economic growth and projected strengthening of the healthcare infrastructure in emerging economies in towards the first half of the following decade is projected to shift the focus of these companies towards highly populous regions of India and China in the long run.

Market Taxonomy

This report segments the global anti-suicide drugs market on the basis of chemistry type, and geography. On the basis of chemistry type, the market is categorized into anti-depressants and anti-anxiety drugs, anti-psychotic drugs, NMDA antagonist and antibiotic analogs. For comprehensive understanding of market dynamics, the global anti-suicide devices market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Anti-Suicide Drugs Market to be on High Growth Trajectory Post Launch of Anti-Suicidal Drug

NeuroRx Pharma has developed a novel anti-suicidal product Cyclurad (D-cycloserine and Lurasidone) which is indicated for Acute Suicidal Ideation/Behavior (ASIB) in Bipolar Depression. The estimated commercialization of the drug post-2020 is expected to be a major breakthrough innovation for the anti-suicide drugs market. Moreover, introduction of other such novel drugs for suicide would augment the anti-suicide market growth. People with major depressive disorder and risk for suicide would greatly benefit from such novel drug therapies.

Anti-Suicide Drugs Market to Gain Initial Traction in Developed Economies

Major players operating in the global anti-suicide drugs market include Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., and Johnson & Johnson. High healthcare expenditure in developed economies of North America and Europe is responsible for a higher market size of anti-suicidal drugs in these regions. Moreover, developed regions offer better healthcare infrastructure and are usually early adopters of new therapies. The anti-suicide drugs market in North America and Europe is expected to gain significant traction during the latter half of the forecast period, with the launch of anti-suicidal drug. Increasing healthcare expenditure in emerging economies and high prevalence of suicides in these regions is expected to bring about a paradigm shift in the market. Companies are expected to focus on capitalizing on lucrative opportunities in these regions at the turn of the following decade. This would ensure sustained growth for the market in the foreseeable future.

Detailed Segmentation:

Global Anti-Suicide Drugs Market, By Chemistry Type:

• Anti-Depressants and Anti-Anxiety Drugs

• Anti-Psychotic Drugs

• NMDA Antagonist

• Antibiotic Analog

Global Anti-Suicide Drugs Market, By Geography:

• North America

• Europe

• Asia-Pacific

• Latin America

• Middle East

• Africa

Grab Your Report at an Impressive Discount @ https://www.coherentmarketinsights.com/insight/request-discount/10

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Development Trends: Global Air Ambulance Services Market Demand and Opportunities 2018-2026

Air Ambulance Services Market

Advancements in healthcare technology along with increasing patient inclination towards faster and efficient mode of delivery has led to rampant growth of efficient and on-the-time delivery air ambulance services market size. Air ambulance services refer to transport or evacuation facilities provided to patients in emergency situations at the accident site, home, or hospital. Air ambulances are equipped with advanced medical facilities, including devices used in emergencies, to provide immediate medical care to the patient until he/she reaches the nearest hospital. Moreover, air ambulances have trained medical crew onboard to treat patients in emergency situations en route to the hospital. Air ambulance efficiently addresses the issue of long travel time and inadequate reach to remote areas faced in road ambulance service. Air ambulance services have thus become an essential component of the modern healthcare system.

Request For Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/6

Increasing use of Helicopters in Air Ambulance

The global air ambulance services market outlook can be analyzed on the basis of type of aircraft as follows:

• Helicopter
• Aircraft/Airplane
• Rotary winged aircraft
• Fixed winged aircraft
• Sea-Planes

Use of helicopters in air ambulance is increasing owing to its convenience in landing and taking-off from a smaller ground area. Moreover, helicopter enables wider reach in remote areas compared to winged aircrafts/airplanes, which require more space for landing and take-off. Companies are also making use of sea planes and corporate planes depending on the demand and patient location.

Lack of Infrastructure and Inadequate Number of Aircraft in Developing Regions are Key Challenges for Growth of Air Ambulance Market

On the basis of geography, the global air ambulance services market scenario can be segmented into North America, Europe, Asia Pacific, Latin America and Rest of the World. Developed infrastructure, defined regulatory framework and favorable reimbursement policies are some of the factors contributing to the dominance of the air ambulance services market in North America and Europe. Developing countries of Asia Pacific, Latina America and Middle East are expected to show swift growth in the demand for air ambulance services. Factors such as rapidly growing medical tourism, improving medical infrastructure, and increasing disposable income are projected to boost growth of air ambulance services market in these regions. Air ambulance service providers in India such as Aviators Air Rescue, Aeromed, Innovation Aviation Pvt Ltd, JetSetGo, Air Ambulance Aviation, and Medanta’s Flying Doctors are collaborating with insurance providers to make the service affordable to all. However, lack of infrastructure and inadequate number of aircraft is deterring operators to meet demand for air ambulance in the country.

Faster Reach and Onboard Assistance Driving Demand

Some key global air ambulance services market drivers include its ability to faster reach compared to road ambulance and onboard medical assistance. Also, air ambulance services are widely utilized on the warfront to rescue injured soldiers and provide emergency medical care to them.

Favorable reimbursement policies for air ambulance services are propelling demand for air ambulance services among patients. Certain insurance providers in Canada reimburse around 80% of the total service cost of air ambulance. This reimbursement policy is applicable for patients who require immediate hospitalization. This policy, however, excludes non-emergency patients, thus increasing cost of this service for such patients. This is a major air ambulance services market restraint. Formulation of strict safety rules by the Federal Aviation Administration (FAA) is one of the factors anticipated to reduce profit margins of air ambulance service providers, which would also hinder the growth of air ambulance services market revenue during the forecast period (2016–2024).

Ambulance Drones: A Fast Emerging Possible Nemesis

Air ambulance service is a capital intensive business, which increases entry barriers for new entrants in the market. Moreover, the advent of ambulance drones will also impact demand for air ambulance in future. The high cost of availing the air ambulance service in comparison to a cheaper ambulance drone would be restrain market growth of air ambulance to a major extent.

In terms of number of players, there are various small players operating with a small fleet of planes across the globe. Some of the major players in the global air ambulance services market are Air Methods Corporation, Deccan Charters, Scandinavian Air Ambulance, Air Ambulance Specialists, Air Charter Service, and Air Methods.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/6

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com

Practice Management System (PMS) Market Countermeasures Of Economic Impact, Entry Strategies And Marketing Channels To 2026

Practice Management System (PMS) Market

Practice management system (PMS) helps manage the daily operations of an organization. These systems find wide application across various verticals in an industry. Increasing investments to upgrade healthcare facilities, especially in developed regions and growth of the healthcare IT industry in developing regions, is creating a highly conducive environment for growth of the practice management systems market. Increasing adoption of PMS has been witnessed in emerging nations such as Indian, China, South Africa, and Brazil, in order to streamline operations and in turn provide better healthcare facilities in these countries. PMS allows for efficient management of health data, patient scheduling, billing process, and referral policies.

Physicians and group organizations need to maintain large amounts of data of day-to-day activities. Practice management system addresses these needs, maintaining critical patient information such as patient demographics, appointment schedule, insurance payer data, billing, and diagnostic and treatment history. Practice management system software are often synchronized with electronic medical record (EMR) or electronic health records (EMR) software for better hospital management.

Ask For Discount Before Purchase This Business Report: https://www.coherentmarketinsights.com/insight/request-discount/68

Increasing hospital visiting on the back of rising prevalence of Chronic and Infectious Diseases creating favorable environment for market growth

• World Health Organization (WHO) estimates that there would be around 24 million cancer cases globally by 2035. In the U.S., over one-third of the adult population is obese, as revealed by statistics released by Centers for Disease Control and Prevention (CDC) (2016). As obesity is a major predisposing factor to various diseases such as diabetes and other cardiovascular diseases, steep rise in patient population is expected in the near future.

• Prevalence of infectious diseases is also on the rise. Moreover, increasing instanced of drug-resistance has mandated physicians to maintain medication history of patient.

• Rapid rise in geriatric population: According to WHO, over 2 billion individuals worldwide will be aged 60 years and above by 2050. A detailed report published by CDC projects that by 2030, 20% of the U.S. population would comprise of geriatric people. The report also details that cardiovascular diseases is the leading cause of deaths in adults aged 65 and above in the U.S.

Rapid rise in patients visiting hospitals mandates efficient keeping of patient history and record maintenance, in turn fueling growth of the practice management systems market.

Key Suppliers In The Global Practice Management Systems Market:

Allscripts Healthcare Solutions, Inc. Henry Schein MicroMD, Athenahealth, Inc., GE Healthcare, NextGen Healthcare Information System LLC, Practice Fusion, McKesson Corporation, Greenway Medical AdvantEgde Healthcare Solutions, MediTouch, and Accumedic Computer Systems.

Practice Management Systems Market Taxonomy:

The global market is segmented as follows:

Software type:

• Desktop-only software - intended for single or few computer sharing access

• Client-server software - allow multiple users to share and access data, and

• Internet-based software - do need separate server for operation

Delivery Platform:

• Web-based

• Cloud

• On-premise

Product Type:

• Integrated

• Standalone

Components:

• Hardware

• Software

End Users:

• Physicians

• Pharmacists

• Diagnostic Laboratories

Browse Full Report @ https://www.coherentmarketinsights.com/ongoing-insight/practice-management-system-market-68

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email: sales@coherentmarketinsights.com